{"transactions":[{"id":961145,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-22T20:44:46.000Z","date":"2025-12-18","kind":"exercise","planned":false,"acquired":false,"shares":14706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":14706,"derivative":{"underlying":"Common Stock","underlying_shares":14706},"source":{"system":"sec-edgar","filing":"0001683168-25-009305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825009305/ownership.xml","form_type":"4"}},{"id":961144,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T20:44:46.000Z","date":"2025-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":5262,"price":1.87,"value":9839.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person forfeited 5,262 shares of Common Stock upon vesting and settlement of 14,706 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's common stock at the time of forfeiture."}],"balance_after":32691,"source":{"system":"sec-edgar","filing":"0001683168-25-009305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825009305/ownership.xml","form_type":"4"}},{"id":961143,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T20:44:46.000Z","date":"2025-12-18","kind":"exercise","planned":false,"acquired":true,"shares":14706,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."}],"balance_after":37953,"source":{"system":"sec-edgar","filing":"0001683168-25-009305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825009305/ownership.xml","form_type":"4"}},{"id":1033163,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-24T20:02:15.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":22541,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23247,"source":{"system":"sec-edgar","filing":"0001683168-25-007223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825007223/ownership.xml","form_type":"4"}},{"id":1058380,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-22T20:00:13.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment No. 1 (\"Form 4/A\") to the Form 4 filed by the reporting person on August 8, 2025 (the \"Original Form 4\") is being filed to correct an administrative error, resulting in the incorrect vesting schedule for the stock option being included in the Original Form 4. As reflected in this Form 4/A, the stock option vests as follows: (i) 25% upon the first anniversary of the grant date, and (ii) the remaining 75% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":85000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001683168-25-006428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825006428/ownership.xml","form_type":"4/A","original_submission_date":"2025-08-08"}},{"id":1071469,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-08T18:45:37.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as follows: (i) 50% upon the first anniversary of the grant date, and (ii) the remaining 50% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":85000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001683168-25-005833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825005833/ownership.xml","form_type":"4"}},{"id":1324341,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-12-20T17:15:07.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":500000,"derivative":{"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001683168-24-008900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316824008900/ownership.xml","form_type":"4"}},{"id":1563620,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-22T18:47:56.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% on the first anniversary of the grant date and (ii) the remaining 50% in 12 equal monthly installments over the 12 months thereafter."}],"balance_after":32000,"derivative":{"exercise_price":1.34,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000950170-24-035553","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000095017024035553/ownership.xml","form_type":"4"}},{"id":1898323,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-05-10T18:46:26.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter."}],"balance_after":125000,"derivative":{"exercise_price":0.13,"expiration_date":"2033-05-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-23-012535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000089924323012535/doc4.xml","form_type":"4"}},{"id":2408678,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-08T17:34:19.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months."}],"balance_after":200000,"derivative":{"exercise_price":1.83,"expiration_date":"2027-02-03","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-22-014166","document":"tm225821d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465922014166/tm225821d2_4.xml","form_type":"4"}},{"id":2513140,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Promissory Note","published_at":"2021-11-15T21:11:31.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"price":0,"reported_value":101200,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Note was scheduled to mature on June 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":3.75,"underlying":"Common Stock","underlying_shares":26986},"source":{"system":"sec-edgar","filing":"0001104659-21-139507","document":"tm2133057-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465921139507/tm2133057-1_4seq1.xml","form_type":"4"}},{"id":2513139,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series Seed-2 Convertible Preferred Stock","published_at":"2021-11-15T21:11:31.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_date":"2021-03-01","underlying":"Common Stock","underlying_shares":1391},"source":{"system":"sec-edgar","filing":"0001104659-21-139507","document":"tm2133057-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465921139507/tm2133057-1_4seq1.xml","form_type":"4"}},{"id":2513138,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-15T21:11:31.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":26986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."}],"balance_after":1199877,"source":{"system":"sec-edgar","filing":"0001104659-21-139507","document":"tm2133057-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465921139507/tm2133057-1_4seq1.xml","form_type":"4"}},{"id":2513137,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-15T21:11:31.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":1391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."}],"balance_after":1172891,"source":{"system":"sec-edgar","filing":"0001104659-21-139507","document":"tm2133057-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465921139507/tm2133057-1_4seq1.xml","form_type":"4"}}]}